David Fajgenbaum

47PUBLICATIONS
143CO-AUTHORS
AllergyPharmacogenomicsMedical molecular engineering of nucleic acids and proteinsAutoimmunityPharmacology and pharmaceutical sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (47)

|Sep 23, 2026
Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab.

|Aug 11, 2026
Development and Validation of the Idiopathic Multicentric Castleman Disease Symptom Burden Scale (ISBUS): Protocol for an International Multistage Mixed Methods Study.

|Apr 02, 2026
Lenalidomide-Dexamethasone as an Effective and Well-Tolerated Treatment Option for Refractory Rosai-Dorfman-Destombes Disease: A Clinical and Pharmacophenomic Study.

Emily Leung, Nicholas R Fragola, Elliott W Sharp

|Mar 12, 2026
Quantify unmet medical need across the disease landscape - A large language model-based methodology.

Elliott W Sharp, Nicholas Fragola, Charlotte Blewitt

|Dec 25, 2025
Dysregulated lymphocyte localization in idiopathic multicentric Castleman disease.

Melanie D Mumau, Michael V Gonzalez, Katherine S Forsyth

|Dec 12, 2025
Medicines, Diseases, Indications, and Contraindications (MeDIC): a foundational resource to support drug repurposing.

Marcello DeLuca, Nico Matentzoglu, Elliott Sharp

Pageof 8

Frequent Collaborators

12 joint publications

Frits van Rhee

11 joint publications

Sheila K Pierson

5 joint publications

Luke Y C Chen

5 joint publications

Joshua D Brandstadter